1
1. Khan MAB, Hashim MJ, King JK, Govender RD. Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends. J Epidemiol Glob Health. 2020;10(1):107–11.
2
2. Okur I, Taspinar B, Telli Atalay O, Pasali Kilit T, Toru Erbay U, Okur EO. The effects of type 2 diabetes mellitus and its complications on physical and pulmonary functions: A case–control study. Physiother Theory Pract [Internet]. 2020 Aug 2;36(8):916–22. Available from:
https://doi.org/10.1080/09593985.2018.1517198
4
4. Saputri RD. Komplikasi Sistemik Pada Pasien Diabetes Melitus Tipe 2. J Ilm Kesehat Sandi Husada. 2020;11(1):230–6.
5
5. Sembiring IS, Rahmawati D, Ramadhan AM. Analisis Efektivitas Biaya dan Minimal Biaya Pasien Diabetes Melitus Tipe 2 di RSUD Abdul Wahab Sjahranie Samarinda Tahun 2019. Proceeding Mulawarman Pharm Conf. 2021;14(3):173–8.
6
6. Balooch Hasankhani M, Mirzaei H, Karamoozian A. Global trend analysis of diabetes mellitus incidence, mortality, and mortality-to-incidence ratio from 1990 to 2019. Sci Rep [Internet]. 2023;13(1):1–8. Available from:
https://doi.org/10.1038/s41598-023-49249-0
7
7. Indonesia KK. Profil Kesehatan Indonesia 2022. Jakarta: Kementerian Kesehatan RI; 2022.
8
8. Milita F, Handayani S, Setiaji B. Kejadian Diabetes Mellitus Tipe II pada Lanjut Usia di Indonesia (Analisis Riskesdas 2018). J Kedokt dan Kesehat. 2021;17(1):9.
9
9. Murtiningsih MK, Pandelaki K, Sedli BP. Gaya Hidup sebagai Faktor Risiko Diabetes Melitus Tipe 2. e-CliniC. 2021;9(2):328–33.
10
10. Amirah AD, Sumiaty, Ella Andayanie. Hubungan Pola Makan Dengan Kejadian Diabetes Melitus Pada Masyarakat Usia Di Atas 40 Tahun Di Kabupaten Gowa. Wind Public Heal J. 2022;3(3):502–15.
11
11. Riau DKP. Profil Kesehatan Provinsi Riau 2022. Pekanbaru: Dinas Kesehatan Provinsi Riau; 2022.
12
12. Molina RT, Ríos García AL, Vergara TA, Florez-Garcia VA, Gutierrez VR, Lozano KF, et al. Predictors of diabetes risk in urban and rural areas in Colombia. Heliyon. 2021;7(1):1–7.
13
13. Ningrum DK. Kepatuhan Minum Obat pada Penderita Diabetes Melitus Tipe II. Higeia J Public Heal Res Dev. 2020;4(3):493–505.
14
14. Beyene A, Habte T, Hailu A. Low-Density lipoprotein cholesterol goal achievement and associated factors among type 2 diabetes mellitus patients at Tikur Anbessa Specialized Hospital in Addis Ababa, Ethiopia: Cross-sectional Study, 2023. Int J Africa Nurs Sci [Internet]. 2024;20(June):100737. Available from:
https://doi.org/10.1016/j.ijans.2024.100737
15
15. Chakraborty S, Verma A, Garg R, Singh J, Verma H. Cardiometabolic Risk Factors Associated With Type 2 Diabetes Mellitus: A Mechanistic Insight. Clin Med Insights Endocrinol Diabetes. 2023;16(1):1–18.
16
16. Latha VA, Mondu SSD, Dinesh Eshwar M, Polala AR, Nandanavanam S, Dodda S. Dyslipidemia Among Diabetes Mellitus Patients: A Case-Control Study From a Tertiary Care Hospital in South India. Cureus. 2023;15(2):1–7.
17
17. Bodaghi AB, Ebadi E, Gholami MJ, Azizi R, Shariati A. A decreased level of high-density lipoprotein is a possible risk factor for type 2 diabetes mellitus: A review. Heal Sci Reports. 2023;6(12):1–11.
18
18. De Rosa S, Arcidiacono B, Chiefari E, Brunetti A, Indolfi C, Foti DP. Type 2 diabetes mellitus and cardiovascular disease: Genetic and epigenetic links. Front Endocrinol (Lausanne). 2018;9(1):1–13.
19
19. Thiruvoipati T. Peripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomes. World J Diabetes. 2015;6(7):961.
20
20. Guan H, Tian J, Wang Y, Niu P, Zhang Y, Zhang Y, et al. Advances in secondary prevention mechanisms of macrovascular complications in type 2 diabetes mellitus patients: a comprehensive review. Eur J Med Res [Internet]. 2024;29(1):1–34. Available from:
https://doi.org/10.1186/s40001-024-01739-1
21
21. Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of Diabetes and Diabetes-Related Complications. Phys Ther. 2008;88(11):1254–64.
22
22. Soegondo. Penatalaksanaan Diabetes Mellitus Terpadu. Jakarta: Balai Penerbit FKUI; 2017.
23
23. Yen FS, Wei JCC, Shih YH, Hsu CC, Hwu CM. The Risk of Nephropathy, Retinopathy, and Leg Amputation in Patients With Diabetes and Hypertension: A Nationwide, Population-Based Retrospective Cohort Study. Front Endocrinol (Lausanne). 2021;12(1):1–10.
24
24. De Faria JBL, Silva KC, Lopes De Faria JM. The contribution of hypertension to diabetic nephropathy and retinopathy: The role of inflammation and oxidative stress. Hypertens Res. 2011;34(4):413–22.
26
26. Kim HJ, Kim K Il. Blood Pressure Target in Type 2 Diabetes Mellitus. Diabetes Metab J. 2022;46(5):667–74.
27
27. Jia G, Sowers JR. Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease. Hypertension. 2021;78(5):1197–205.
28
28. Petrie JR, Guzik TJ, Touyz RM. Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Can J Cardiol [Internet]. 2018;34(5):575–84. Available from:
https://doi.org/10.1016/j.cjca.2017.12.005
29
29. Vadila A, Izhar MD, Nasution HS. Faktor-Faktor Kejadian Diabetes Melitus Tipe 2 di Puskesmas Putri Ayu. Media Kesehat Politek Kesehat Makassar. 2021;XVI(2):229–37.
30
30. Sreedevi A, Krishnapillai V, Menon VB, Mathew MM, Nair RR, Pillai GS, et al. Uncontrolled Blood Pressure and Associated Factors Among Persons With Diabetes: A Community Based Study From Kerala, India. Front Public Heal. 2022;9(1):1–7.
31
31. Naaman SC, Bakris GL. Diabetic Nephropathy: Update on Pillars of Therapy Slowing Progression. Diabetes Care. 2023;46(9):1574–86.
32
32. Raflin BR Sinaga M, Yensuari Y, Dharma S. Pengaruh Kendali Glukosa Darah, Hipertensi, Dan Dislipidemia Terhadap Komplikasi Retinopati Diabetik Pada Penderita Diabetes Melitus Tipe 2. J Multidisiplin Indones. 2023;2(10):3304–19.
33
33. Sun B, Huang XS. Painful peripheral neuropathy. Chinese J Contemp Neurol Neurosurg. 2013;13(9):755–9.
34
34. Rizvi AA. Addressing Hypertension in the Patient with Type 2 Diabetes Mellitus: Pathogenesis, Goals, and Therapeutic Approach. EMJ Diabetes. 2017;5(1):84–92.
35
35. Tandra H. Segala Sesuatu yang Harus Anda Ketahui tentang Diabetes. Jakarta: Gramedia Pustaka Utama; 2018.
36
36. Bin Rakhis SA, AlDuwayhis NM, Aleid N, AlBarrak AN, Aloraini AA. Glycemic Control for Type 2 Diabetes Mellitus Patients: A Systematic Review. Cureus. 2022;14(6):6–13.
37
37. Quraisy CCRSA, Mulyani NS. Faktor-faktor yang Berhubungan dengan Kejadian Fiabetes Mellitus Tipe-II pada Pasien Rawat Jalan. J SAGO Gizi dan Kesehat. 2021;2(2):122.